Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
7M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$1.41M
-
Value change
-
-$885K
-
Put/Call ratio
-
3.05
-
Number of buys
-
10
-
Number of sells
-
-11
-
Price
-
$0.20
Significant Holders of Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) as of Q4 2023
36 filings reported holding AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7M shares
of 60.4M outstanding shares and own 11.59% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.66M shares), ORBIMED ADVISORS LLC (2.65M shares), RENAISSANCE TECHNOLOGIES LLC (327K shares), VANGUARD GROUP INC (286K shares), BlackRock Inc. (207K shares), GEODE CAPITAL MANAGEMENT, LLC (207K shares), HRT FINANCIAL LP (118K shares), MILLENNIUM MANAGEMENT LLC (114K shares), CITADEL ADVISORS LLC (108K shares), and Virtu Financial LLC (75K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.